ISSN (Print): 1570-159X
ISSN (Online): 1875-6190
Volume 19, 12 Issues, 2021
Download PDF Flyer
Open Access Funding
Promote Your Article
ISSN (Print): 1570-159X
ISSN (Online): 1875-6190
Aims & Scope
Science Citation Index Expanded (SciSearch®), Journal Citation Reports/Science Edition, InCites, Neuroscience Citation Index®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/PubMed Central, Europe PMC, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, ChemWeb, Google Scholar, PsycINFO, ProQuest, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, Ulrich's Periodicals Directory, JournalTOCs and Dimensions.
Ranking and Category:
69 th of 261 in Neurosciences 40 th of 261 in Pharmacology & Pharmacy
Submit Abstracts / Manuscripts Online
Animated Abstract Submission
View Full Editorial Board
5 - Year: 5.470
Self Archiving Policies
Instructions for Authors
Free Copies Online
Open Access Articles
Most Cited Articles
Advertise With Us
Most Accessed Articles
Most Popular Articles
Special Issue Submission
Editor(s): Simone Peschillo
eISBN: 978-1-68108-005-5, 2015
ISBN: 978-1-68108-006-2 ISSN: 2405-7401 (Print) ISSN: 2405-741X (Online)
Remarkable advances have been made in embolization of cerebral aneurysms, arteriovenous malformations and stroke treatment during the past decades. Endovascular techniques are less invasive than other forms of neurosurgery. However, endovascular neurosurgery is becoming more complicated as the technology is becoming more sophisticated. Frontiers in Neurosurgery is an ebook series which triggers principle issues that still fuel debate in neurosurgery. The series is intended as a reference for practicing endovascular neurosurgeons, vascular neurosurgeons, interventional neurologists and neuroradiologists who have a solid knowledge of neuroangiography.
The first volume of this series brings reviews on a variety of challenges that neuroendovascular surgeons can face such as:
- Devices for Neuroendovascular Treatment
- Dual Antiplatelet Therapy in Neuroendovascular Procedures
- Endovascular Reperfusion Management for Acute Ischemic Stroke
- Spinal Vascular Pathology
- Anesthesia Options for Endovascular Neurosurgery … and much more.
Editor(s): Federico A. Landriel and Eduardo Vecchi
eISBN: 978-1-68108-122-9, 2016
ISBN: 978-1-68108-123-6 ISSN: 2405-7401 (Print) ISSN: 2405-741X (Online)
This video atlas covers a broad range of spinal surgical procedures. The volume includes a collection of high quality 3-to-8 minute videos of some of the most critical spine operations performed by internationally renowned expert surgeons.
Key features of the book contents include:
o Downloadable high quality video content with subtitles suitable for viewing on any display (A brief preview of the book content can be viewed at https://www.youtube.com/watch?v=SxMi4UFj7HA )
o Detailed descriptions of surgical indications, preoperative planning, patient positioning, surgical technique, complications, postoperative care and outcomes for each procedure
o Full color images and illustrations highlighting different key stages of each surgical technique
The video format allows skill development of its intended audience by conveying temporal and spatial details which often go unnoticed in photograph format. This volume will be of immense interest to both the novice and the experienced spinal surgeon as they can benefit from the visual guides presented in the book. It also serves as an ideal teaching tool for spine surgery units in medical schools.
eISBN: 978-1-68108-309-4, 2016
ISBN: 978-1-68108-310-0 ISSN: 2405-7401 (Print) ISSN: 2405-741X (Online)
Stroke is thought to be the second biggest killer worldwide, and is responsible for over 5 million deaths per year. Several strategies have been developed to enhance treatment of stroke patients. Multimodal neuroimaging allows physicians to diagnose and evaluate not only the ischemic core but also the vessel pattern and collateral status. Stroke Treatment involves extensive intravenous drug administration. Several new drugs with long lasting efficacy are now being tested in randomized clinical trials. In this context, endovascular treatment is a promising avenue that allows physicians to treat patients in extended time windows especially patients in whom intravenous RTPA has failed. A new era has emerged with new devices called stent retrievers and aspiration techniques, which have demonstrated higher rates of recanalization and clear superiority over previous devices employed in RCTs.
The third volume of Frontiers in Neurosurgery presents updated information on ischemic stroke treatment. The volume comprehensively covers the epidemiology, physiology, diagnosis and treatment modalities of stroke. Readers will also find key information on diagnosing and treating rare and lesser known causes of stroke as well as notes about new devices and medical procedures to combat ischemic stroke. This volume is a useful resource for neurosurgery specialists as well as nurses, physiotherapists and caregivers.
Editor(s): Songtao Qi
Co-Editor(s): Jun Pan and Yuntao Lu
eISBN: 978-1-68108-532-6, 2017
ISBN: 978-1-68108-533-3 ISSN: 2405-7401 (Print) ISSN: 2405-741X (Online)
Craniopharyngiomas are a type of brain tumour in the suprasellar region with benign histological and cellular features. Clinical manifestations of craniopharyngiomas include decreased vision, hypopituitarism, hypothalamus dysfunction, fluid and electrolyte imbalance, glycometabolism, lipid metabolism and obesity. Craniopharyngiomas can show some characteristics of malignant tumours, such as invasion to the surrounding tissues, repetitious recurrence, and rapid growth. These characteristics cause considerable difficulty in patient treatment for neurosurgeons all over the world. This volume presents detailed information about craniopharyngioma anatomy, classification and treatment.
Author(s): Pierre Nelson and Gérard Lot
eISBN: 978-1-60805-982-9, 2015
How do neurons work in processes that guide thought and action? This eBook answers this question by presenting an accurate analysis of all the physico-chemical phenomena occurring between interconnected neurons. Once researchers have this information, they can then build a functional catalog of neurons and understand the working behind the simplest physiological elements and these can hopefully be replicated into devices. Microscopic and macroscopic experimental results can assist in the study of sensorial analysis, instincts and motor control of skeletal muscles. The book also presents a description of memory at the cellular level and gives insights about the learning process in living systems. Such research has increased our understanding of the mechanisms of animal behaviors from the honeybee to the dog. In human beings, the efficiency of the same neural mechanisms overtakes a threshold when language allows building new abstract signals from previous abstract signals. Introduction to the Neural Basis of Action and Thought demonstrates to readers how physiological processes allow us to recall words and generate sentences and how these processes support abstract thought, action and self awareness. This book is a useful primer for anyone interested in cognitive sciences and related research.
Editor(s): Ahmad Salehi, Michael Rafii and Cristy Phillips
eISBN: 978-1-68108-138-0, 2015
ISBN: 978-1-68108-139-7 ISSN: 2452-2554 (Print) ISSN: 2452-2562 (Online)
Recent Advances in Alzheimer Disease Research is a book series focusing on contemporary research on Alzheimer’s disease epidemiology, pathophysiology, diagnosis and therapy. The series features reviews by experts in neuroscience and aims to provide current information in the field to both researchers and clinicians.
Down syndrome is a chromosomal disorder affecting more than 5.8 million individuals worldwide. Down syndrome can be viewed as a complex multi-system disorder as it manifests into significant physical, psychological, and cognitive abnormalities in affected persons. With aging, most adults with Down syndrome develop the clinical and neuropathological hallmarks of Alzheimer's disease. Unfortunately, no extant treatments have proven beneficial for cognitive dysfunction for either Down syndrome or Alzheimer’s disease. An incomplete understanding of the common pathogenic mechanisms that link these two disorders has limited researchers’ progress to this end. Common Pathogenic Mechanisms between Down syndrome and Alzheimer's Disease: Steps toward Therapy is a novel attempt to fill this void, by summarizing the work of world-renowned scientists in the field of Alzheimer’s disease and Down syndrome, and thus providing an unprecedented opportunity to attract attention to Down syndrome as a tool for understanding the common molecular mechanisms that underlie Alzheimer’s disease and to develop new therapies for similar neurodegenerative disorders of the brain.
The book covers the fundamental pathophysiology and molecular mechanisms behind the incidence of Alzheimer’s disease in Down syndrome affected individuals as well other key topics such as diagnosis and management, in vivo brain imaging studies, and progressive neurodegeneration of the monoaminergic system. The book concludes with a review of recent clinical trials of drugs designed to mitigate cognitive dysfunction in aging adults with Down syndrome and establishes a scientific warrant for the increased testing of candidate pharmacotherapies.
Common Pathogenic Mechanisms between Down syndrome and Alzheimer's Disease: Steps toward Therapy is a useful reference clinicians involved in treating Down syndrome patients as well as for neuroscience researchers seeking to understand the influence of a specific case of aneuploidy on Alzheimer’s disease incidence and its progression at the molecular level.
Editor(s): Fernando A. Oliveira
eISBN: 978-1-68108-715-3, 2018
ISBN: 978-1-68108-716-0 ISSN: 2452-2554 (Print) ISSN: 2452-2562 (Online)
Alzheimer’s Disease (AD) is the product of the slow and progressive degenerative alteration that develops in the adult brain and can remain asymptomatic for a considerable time before cognitive deficits becomes evident. The main challenge for researchers is to identify markers of this degenerative process, and, in this sense, data has been generated through experiments bringing to light new mechanisms and hypothesis to explain its pathophysiology.
This book is a review of recent studies in AD molecular biology. Chapters explain various facets of AD, which include animal models, morphological changes, membrane composition, amyloidogenic peptides, intracellular transport systems, and the role of oxidative stress and calcium deregulation.
Readers will understand the molecular mechanisms behind AD and therefore broaden their perspective on this neurodegenerative disease and its progression.
Editor(s): Blas Gil-Extremera
eISBN: 978-981-14-0513-6, 2019
ISBN: 978-981-14-0512-9 ISSN: 2452-2554 (Print) ISSN: 2452-2562 (Online)
Alzheimer's disease is the most frequent cause of dementia that slowly and progressively causes cognitive impairment and profoundly alters the daily activities of the patients. Approximately, ten percent of all persons over the age of seventy experience significant memory loss, and in more than half of the cases, the cause is Alzheimer's disease.
This reference book is an update on the most relevant pathological and clinical findings of this
neurological disorder. Chapters cover the basic hypothesis of Alzheimer’s disease, pathological features of the disease in the brain, Alzheimer’s disease diagnosis and therapy. Information provided in the book is focused on research in developed countries.
The book offers students of medicine and nursing as well as medical practitioners and specialists (internists, neurologists, gerontologists, and psychiatrists), the necessary information to understand the pathological and clinical aspects of the disease in depth, with the goal of improving medical outcomes in the care of their patients.
Author(s): Felix-Martin Werner and Rafael Coveñas
eISBN: 978-1-68108-215-8, 2016
Schizoaffective disorder is a psychotic disease with schizophrenic and affective i.e. depressive and/or manic symptoms. The disease can result in different patient outcomes depending upon the treatment applied. Patients suffering from the disease have in increased vulnerability towards stress and need an appropriate prophylactic medication so that they can perform social and maybe professional activities. Classical Neurotransmitters and Neuropeptides involved in Schizoaffective Disorder is a brief monograph that gives readers an overview of frequent psychotic diseases affecting patients. The contents of the monograph include details about biochemical alterations of classical neurotransmitters and neuropeptides in specific regions of the human brain, the susceptible genes and cellular mechanisms behind schizoaffective disorder, the neural networks of schizoaffective disorder and prophylactic pharmacotherapies administered to patients. Three case reports which demonstrate the alterations of classical neurotransmitters and neuropeptides in the brain are also presented. This monograph is a useful guide for medical residents and clinicians in training who wish to understand the basics about treating patients suffering from schizoaffective disorder.
Editor(s): Tuck Yean Yong
eISBN: 978-1-68108-245-5, 2016
ISBN: 978-1-68108-246-2 ISSN: 2468-2241 (Print) ISSN: 2468-225X (Online)
The incidence of multiple chronic diseases affecting a single individual is common among elderly patients. This incidence is believed to be associated with a decline in many health outcomes, including quality of life, mobility, functional ability, increased frequency of hospitalizations, psychological distress, mortality and the use of health care resources. Health in elderly patients can fluctuate significantly, thus prompting the need for proper integration of comprehensive geriatric care. An increasing amount of data gained from research programs is making it clear that a geriatric assessment identifies many problems in older people with chronic diseases, adds prognostic information, and might improve the outcomes of these patients. This volume reviews research on the value of geriatric programs in different subspecialties of internal medicine. Chapters of this book cover different chronic diseases (coronary artery disease, kidney disease, diabetes, osteoporosis etc.) separately and present new findings in these areas. Readers – both medical students and researchers – will find the book an essential for understanding requirements and nuances of specialized geriatric programs in the healthcare sector.
Editor(s): Jeremy W. Grabbe
eISBN: 978-1-68108-451-0, 2017
ISBN: 978-1-68108-452-7 ISSN: 2468-2241 (Print) ISSN: 2468-225X (Online)
According to the National Institute of Aging there are more than half a billion people over the age of 65 across the globe. This has led to a need for medical and psychiatric care on a scale unprecedented in history. In light of this increase in the global elderly population, the field of geriatric medicine has expanded and become multidisciplinary to accommodate the need of the elderly in the 21st century.
This volume highlights research in geriatric medicine across different disciplines. Chapters of this volume cover public health and economic consequences of aging in USA, cognitive impairment in old age, geriatric ophthalmology, osteoporosis, sleep disorders, speech-language pathology and geriatric care. Readers – both medical students and researchers - will find these topics useful for understanding issues in geriatric medicine and can use this information to improve geriatric programs in the healthcare sector.
Author(s): Shanthi Mendis
eISBN: 978-1-68108-524-1, 2017
ISBN: 978-1-68108-525-8 ISSN: 2542-5110 (Print) ISSN: 2542-5129 (Online)
Stroke is one of the most debilitating diseases which poses a significant economic burden on society. Increasing exposure to behavioural risk factors for stroke (tobacco use, unhealthy diet, physical inactivity and excessive alcohol consumption) and air pollution are driving up the worldwide stroke burden. Although medical interventions to prevent and manage stroke have advanced considerably over the last two decades, they are not consistently implemented worldwide. Therefore, health outcomes of stroke treatment vary throughout the world.